Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fenner

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
The Journal of Frailty & Aging|February 9, 2019
HbA1c Is Associated with Frailty in a Group of Aboriginal AustraliansZ Hyde, K Smith, L Flicker, et al.
Biochemical Pharmacology|November 9, 2011
Absolute immunoquantification of the expression of ABC transporters P-glycoprotein, breast cancer resistance protein and multidrug resistance-associated protein 2 in human liver and duodenumTheodora G H A Tucker, Alison M Milne, Sylvie Fournel-Gigleux, et al.
British Poultry Science|March 25, 1998
Effects of AvGard treatment on the microbiological flora of poultry carcasesG Salvat, P Coppen, J C Allo, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 15, 2011
The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearanceKatherine S Fenner, Hannah M Jones, Mohammed Ullah, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 17, 2001
Absorption, distribution, metabolism, and excretion considerations in selection of orally active indole-containing endothelin antagonistD K Walker, K N Dack, R P Dickinson, et al.
Clinical Pharmacology and Therapeutics|November 7, 2008
Drug-drug interactions mediated through P-glycoprotein: clinical relevance and in vitro-in vivo correlation using digoxin as a probe drugK S Fenner, M D Troutman, S Kempshall, et al.
Journal of Pharmaceutical Sciences|April 18, 2009
N-(3,4-dimethoxyphenethyl)-4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2[1H]-yl)-6,7-dimethoxyquinazolin-2-amine (CP-100,356) as a "chemical knock-out equivalent" to assess the impact of efflux transporters on oral drug absorption in the ratAmit S Kalgutkar, Kosea S Frederick, Jonathan Chupka, et al.
Research in Veterinary Science|February 23, 2010
Analysis of 16S rDNA sequences from pathogenic Leptospira serovars and use of single nucleotide polymorphisms for rapid speciation by D-HPLCJ S Fenner, M F Anjum, L P Randall, et al.
Current Drug Metabolism|December 30, 2010
Targeting intestinal transporters for optimizing oral drug absorptionManthena V Varma, Catherine M Ambler, Mohammad Ullah, et al.
British Journal of Clinical Pharmacology|March 12, 2011
A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladderErnesto Callegari, Bimal Malhotra, Peter J Bungay, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
The Journal of Frailty & Aging|February 9, 2019
HbA1c Is Associated with Frailty in a Group of Aboriginal AustraliansZ Hyde, K Smith, L Flicker, et al.
Biochemical Pharmacology|November 9, 2011
Absolute immunoquantification of the expression of ABC transporters P-glycoprotein, breast cancer resistance protein and multidrug resistance-associated protein 2 in human liver and duodenumTheodora G H A Tucker, Alison M Milne, Sylvie Fournel-Gigleux, et al.
British Poultry Science|March 25, 1998
Effects of AvGard treatment on the microbiological flora of poultry carcasesG Salvat, P Coppen, J C Allo, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 15, 2011
The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearanceKatherine S Fenner, Hannah M Jones, Mohammed Ullah, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 17, 2001
Absorption, distribution, metabolism, and excretion considerations in selection of orally active indole-containing endothelin antagonistD K Walker, K N Dack, R P Dickinson, et al.
Clinical Pharmacology and Therapeutics|November 7, 2008
Drug-drug interactions mediated through P-glycoprotein: clinical relevance and in vitro-in vivo correlation using digoxin as a probe drugK S Fenner, M D Troutman, S Kempshall, et al.
Journal of Pharmaceutical Sciences|April 18, 2009
N-(3,4-dimethoxyphenethyl)-4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2[1H]-yl)-6,7-dimethoxyquinazolin-2-amine (CP-100,356) as a "chemical knock-out equivalent" to assess the impact of efflux transporters on oral drug absorption in the ratAmit S Kalgutkar, Kosea S Frederick, Jonathan Chupka, et al.
Research in Veterinary Science|February 23, 2010
Analysis of 16S rDNA sequences from pathogenic Leptospira serovars and use of single nucleotide polymorphisms for rapid speciation by D-HPLCJ S Fenner, M F Anjum, L P Randall, et al.
Current Drug Metabolism|December 30, 2010
Targeting intestinal transporters for optimizing oral drug absorptionManthena V Varma, Catherine M Ambler, Mohammad Ullah, et al.
British Journal of Clinical Pharmacology|March 12, 2011
A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladderErnesto Callegari, Bimal Malhotra, Peter J Bungay, et al.
Pageof 3